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Aim: To analyse 24 hour variations in intraocular pressure
(IOP) and central corneal thickness (CCT) in a group of
glaucomatous patients.
Methods: 30 patients with primary open angle glaucoma
were hospitalised and underwent circadian evaluations (at
8 pm, midnight, 4 am, 8 am, noon, and 4 pm) of supine and
sitting IOP, respectively, measured using a Perkins and a
Goldmann tonometer, and CCT measured using an ultra-
sonic pachymeter (the mean value of three measurements
within 5 mm). All patients were treated with timolol 0.5%
twice daily and latanoprost 0.005% once daily.
Results: Mean supine IOP was 15.3 (SD 3.7) mm Hg (range
10–25), with circadian fluctuations of 7.3 (3.3) mm Hg.
Mean sitting IOP was 15.1 (3.9) mm Hg (range 8–26), with
circadian fluctuations of 5.4 (3.1) mm Hg. Mean CCT was
534 (39) mm (range 443–637 mm) with circadian fluctua-
tions of 16.5 (6.2) mm (range 6–31 mm). Both the within
patient and within time point fluctuations in CCT were
statistically significant (p,0.0001, ANOVA).
Conclusions: The authors found considerable fluctuations in
24 hour IOP. The circadian fluctuations in CCT were small
and, although statistically significant, did not seem to
interfere with the circadian IOP assessment.
I
ntraocular pressure (IOP) is an important parameter for
glaucoma detection and follow up and, since the beginning
of its medical treatment, reducing IOP has been the only
way of slowing or halting disease progression. Like all
biological parameters, IOP fluctuates over 24 hours,1–5 but
the extent of the fluctuations and their importance in
glaucoma patients are still debated.6–9
The ‘‘gold standard’’ for IOP evaluation is Goldmann
tonometry, which is highly precise and shows the least
interobserver variability. However, various factors can reduce
its reliability,10–14 one of the most important of which is
central corneal thickness (CCT). Although the effect of CCT
on IOP measurements was assumed by Goldmann12 in 1957,
and then experimentally demonstrated by Ehlers15 in 1975, it
is only recently that the problems in measuring IOP created
by refractive surgery have underlined its clinical impor-
tance.16 17 Though a number of cross sectional studies have
shown that ocular hypertensive eyes have thicker mean
CCT,18–23 whereas low tension glaucoma (LTG) is charac-
terised by lower mean CCT,19 21 23–25 and primary open angle
glaucoma (POAG) by normal mean CCT,19 21 individual
corneal thickness largely varies and overlaps between groups.
Nevertheless, pachymetry is important to correctly classify
and diagnose these conditions.18 19 21 23 26
There are still many unanswered questions concerning
CCT. First of all, although many correcting factors have been
proposed in order to obtain an estimate of ‘‘actual’’ IOP with
respect to CCT, there is still no agreement about their clinical
usefulness.15 22 23 27–29
Furthermore, there is no pachymetric ‘‘gold standard.’’
Ultrasonic pachymeters are the most used in clinical settings;
they are generally portable and easy to use, but they require
adequate training because probe alignment and perpendicu-
lar contact with the central cornea are critical to ensure
reliable data.30 Ultrasonic pachymetry provides the most
precise CCT measurements,30 and its interoperator and
intraoperator reproducibility is good,31 but its accuracy has
recently been questioned because it can overestimate CCT in
comparison with confocal microscopy.30 In an attempt to
avoid these limitations, various non-contact pachymeters
(optical devices, confocal microscopy,32 and optical coherence
tomography33) have been introduced into clinical practice.
The variability of corneal thickness is a further controver-
sial issue. Most studies have considered CCT a ‘‘static’’
parameter and ignored its possible fluctuations (as correctly
pointed out in Doughty’s meta-analysis34), and more recent
studies of CCT variability have considered only daytime
fluctuations,31 35 with the exception of Harper’s study of
circadian variations in normal subjects.36
The aim of this study was to evaluate the circadian
fluctuations of CCT in a group of glaucomatous patients, and
their potential effects on IOP assessments.
PATIENTS AND METHODS
The study was carried out at the San Paolo Hospital Eye
Clinic of the University of Milan. The patients attending the
glaucoma service underwent a complete ophthalmic exam-
ination in order assess their eligibility, and 30 consecutive
glaucomatous patients were enrolled (see table 1). In order to
avoid the effects of different medical treatments, only
patients treated with an unfixed association of timolol
maleate 0.5% twice daily and latanoprost 0.005% once daily
were considered.
The inclusion criterion was bilateral POAG, defined as an
untreated IOP .21 mm Hg (measured on two consecutive
occasions separated by an interval of at least 2 hours but no
more than 12 weeks), a glaucomatous visual field (on the
basis of at least two reliable Humphrey 30–2 full threshold
tests), and glaucomatous optic disc changes (evaluated by
means of colour stereophotographs) or retinal nerve fibre
layer defects (evaluated by means of a scanning laser
ophthalmoscope).
The exclusion criteria were low tension, exfoliation,
pigmentary or secondary glaucomas; previous refractive
surgery; any ocular surgery less than 3 months before
enrolment; present or past contact lens wear; present or
past corneal disease or injury; significant tear secretion
Abbreviations: CCT, central corneal thickness; COV, coefficient of
variation; CPSD, corrected pattern standard deviation; IOP, intraocular
pressure; LTG, low tension glaucoma; MD, mean defect; POAG, primary
open angle glaucoma
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abnormality; significant wake-sleep rhythm disturbances;
and hypnotic drug consumption.
Before enrolment, the procedures and the aims of the study
were carefully explained to the patients, who signed an
informed consent form approved by the ethics committee of
San Paolo Hospital. The study was performed according to
the Declaration of Helsinki.
The enrolled patients were hospitalised at 7 pm to undergo
a circadian evaluation of CCT, and supine and sitting IOP in
one randomly chosen eye (randomisation by means of a list
of random numbers), as previously described.4 5 Briefly, the
measurements were made at 8 pm, midnight, 4 am, 8 am,
noon, and 4 pm; the 8 pm, and 8 am measurements were
made before the instillation of timolol maleate 0.5%.
Latanoprost was instilled at 10 pm.
One drop of oxibuprocaine and fluorescein was instilled
before each measurement. Supine IOP was measured by
means of a Perkins tonometer, after which the patients
walked about 10 metres to the ophthalmic cabinet and their
sitting IOP was measured using a Goldmann tonometer.
Finally, CCT was measured on the mid-pupillary/papillary
axis (the mean of three readings within 5 mm) using a DGH
2000 AP ultrasonic pachymeter (DGH Technology Inc, San
Diego, CA, USA).
A slit lamp examination was performed before each CCT
measurement in order to ensure the absence of corneal
epithelial defects. No dilation or gonioscopy was used during
the study period in order to avoid any corneal surface damage
or distortion.37
Statistical analysis
The tonometric measurements were made by two experi-
enced observers (PF and FM), whose concordance was
evaluated before the eligibility examination by means of
the calculation of kappa statistics (k)38 over 50 measurements
each using the Perkins and Goldmann tonometers. A cut-off
point of 2 mm Hg (the lowest published interobserver
variability for Goldmann tonometry)39 was used to define
agreement, which was found to be excellent (k= 0.84).
The CCT measurements were made by a single observer
(PF). Intraobserver agreement was evaluated by comparing
50 CCT measurements of a single eye of a volunteer. Ten
measurements were made on the same day at each time point
of 8 am, 10 am, noon, 2 pm, and 4 pm, and agreement was
defined as the presence of values within plus or minus 5 mm
of the mean CCT (corresponding to the 95% confidence
interval40). The mean CCT was 507 (SD 3) mm, and the
agreement was excellent (k= 0.94).
The IOP and CCT data are given as mean values, standard
deviations, and ranges. The coefficient of variation (COV,
defined as the percentage standard deviation divided by the
mean) was also calculated in order to facilitate comparisons
with the variations reported in other studies.
The t test for paired samples was used to compare mean
supine and sitting IOP. Two way analysis of variance for
repeated observations38 was used to test the hypothesis that
there were no significant within patient or within time point
changes in CCT changes during the circadian evaluation.
The Bravais-Pearson coefficient of linear correlation (r)
was used to check the correlations between the following
variables: mean CCT; variations in CCT (percentage, standard
deviation, and COV); mean supine IOP; variations in mean
supine IOP; mean sitting IOP; variations in mean sitting IOP;
mean defect and corrected pattern standard deviation at
standard automated perimetry; and refraction. The correla-
tion was considered negligible if r,0.2; weak if 0.2,r,0.5;
good if 0.5,r,0.8; strong if r.0.8.38
RESULTS
The key results of the study are summarised in table 2. IOP
and CCT data of patients operated of cataract surgery (seven
patients) or trabeculectomy (two patients) were comparable
to data of patients who did not undergo eye surgery.
Mean supine IOP was 15.3 (SD 3.7, range 10–25) mm Hg;
mean sitting IOP was 15.1 (SD 3.9, range 8–26) mm Hg; and
mean CCT was 534 (SD 39, range 443–637) mm (see fig 1 for
the distribution of mean CCT values).
Table 1 Main patient characteristics
Number of subjects 30
Race, white 30
Age range, years 55–84
Sex 12 F, 18 M
Refraction (D), mean (SD) 20.9 (4.2)
MD (dB), mean (SD) 26.6 (8.0)
CPSD (dB), mean (SD) 5.6 (4.5)
MD: mean defect; CPSD: corrected pattern standard
deviation.
Table 2 Main results of the study
Supine IOP
(mm Hg)
Sitting IOP
(mm Hg) CCT (mm)
Mean value 15.3 15.1 534
Standard deviation 3.7 3.9 39
Range 10–25 8–26 443–637
Coefficient of variation 24.2% 25.8% 7.3%
Mean results at each time point
8 pm 15.2 15.3 529.8
Midnight 16.5 15.7 535.9
4 am 15.7 15.0 538.9
8 am 15.9 15.2 535.5
Noon 14.2 14.9 531.7
4 pm 14.2 14.8 529.5
Standard deviation* 0.93 0.34 3.8
Coefficient of variation* 6.1% 2.6% 0.7%
Mean results per patient over the 24 hours
Coefficient of variation (SD) 18.8% (7.5%) 13.4% (6.7%) 1.2% (0.4%)
Range 6.6%–33.1% 3.6%–36.5% 0.4%–2.4%
Mean individual variation 7.3 (3.3) 5.4 (3.1) 16.5 (6.2)
Percentage (SD) 63% (33%) 45% (33%) 3.2% (1.2%)
Range 3–15 1–17 6–31
Percentage 22%–150% 7%–189% 1.1%–6.2%
*Considering the mean values at the six time points.
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Figure 2 shows the 24 hour curves of mean supine and
sitting IOP, and CCT. There were no significant changes in
supine IOP at any time point, although it peaked at midnight
(16.5 mm Hg) and troughed at noon and 4 pm
(14.2 mm Hg), nor any significant change in sitting IOP
(mean values between 14.8 mm Hg and 15.7 mm Hg). The
same was true when the day and night-time measurements
were compared. Mean time point CCT ranged from 530–
539 mm, with a 0.7% COV comparing all time points.
Variability became more important when the within
patient curves were considered. The mean variations in
supine and sitting IOP were respectively 7.3 (3.3) mm Hg and
5.4 (3.1) mm Hg (fig 3), and mean CCT changes were 16.5
(6.2) mm, with mean COV = 1.2 (0.4%) (figs 4 and 5). The
distribution of CCT peaks and troughs over time is shown in
figure 6. In terms of the values at each time point, the
difference between peak CCT (at 4 am) and trough CCT (at
4 pm) was about 9 mm (p,0.0001, ANOVA; table 3).
The Bravais-Pearson coefficient of linear correlation was
negligible or weak for all of the variables except for the good
correlations between mean supine IOP and mean CCT
(r= 0.53), and between mean sitting IOP and mean defect
at standard automated perimetry (r= 0.64). In particular,
there were negligible or weak correlations for CCT COV and
CCT (r=20.11), mean supine IOP (r = 0.02) and its
variation (r = 0.11), and mean sitting IOP (r=20.10) and
its variation (r= 0.42).
The CCT curve shown in figure 2 was recalculated in terms
of the percentage deviation from the mean (considered as
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Figure 1 Central corneal thickness in the study population.
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Figure 2 Mean circadian curves of supine IOP (mm Hg), sitting IOP
(mm Hg), and CCT (mm). The bars represent standard errors.
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Figure 3 Variations in supine and sitting IOP over 24 hours.
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Figure 4 Coefficient of variation (COV) of central corneal thickness
(CCT) over 24 hours.
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Figure 5 Patient CCT variations (mm) over 24 hours.
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Figure 6 Frequency of CCT peaks and troughs at each time point. Both
distribution curves are gaussian, with mean peaks at 4 am and mean
troughs at 4 pm.
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100%) in order to compare it with the circadian CCT curve
estimated by Doughty in his meta-analysis of normal, non-
white subjects.34 As shown in figure 7, the two curves were
very similar except for the fact that our 24 hour variations did
not exceed plus or minus 1%, whereas Doughty’s were about
plus or minus 2%.
DISCUSSION
To the best of our knowledge this is the first study of
circadian variations in CCT and their relations to supine and
sitting IOP in a group of glaucomatous subjects. A 48 hour
study of CCT was published by Harper et al on a small group
(n = 8) of normal subjects to evaluate fluctuations in CCT
during the sleep phase.36 Conversely, the main objective of
the present study was to evaluate circadian CCT variations in
a group of glaucomatous patients and their role in the
circadian assessment of IOP.
We found very small variations in circadian supine and
sitting IOP, with mean values of respectively 15.3 (0.9)
mm Hg and 15.1 (0.3) mm Hg; the biggest difference of
2.3 mm Hg found in the supine curve between midnight and
noon values was neither clinically nor statistically significant.
When comparing this finding with previously published
data,1–5 it is necessary to consider the possibility of the
treatment induced stabilisation of circadian IOP values.
Greater fluctuations in 24 hour IOP were found when the
within patient curves were analysed, with mean variations of
7.3 (range 3–15) mm Hg in supine IOP, and mean variations
of 5.4 (range 1–17) mm Hg in sitting IOP. Goldmann
tonometry revealed fluctuations of more than 5 mm Hg in
about 60% (fig 3) despite the use of treatment schedules that
are considered to be very effective in the majority of clinical
settings. Although there were no significant differences in
daytime v night-time IOP values, 50% of the supine and 40%
of the sitting IOP peaks occurred at midnight or 4 am, thus
confirming the clinical importance of circadian IOP evalua-
tions in order to be sure of treatment efficacy in glaucoma-
tous patients.4 5 The timings found in our study seem to
confirm previous findings by Liu et al in glaucomatous
patients40 and young healthy subjects.41
The mean CCT values were very similar to those reported in
the literature.23 34 The high range in CCT values (443–637 mm)
in our homogeneous sample of POAG patients receiving the
same therapy confirms the importance of individual assess-
ments in better estimating ‘‘true’’ IOP and detecting possible
risk factors for disease progression.42
The 24 hour variations in CCT were small: mean within
patient variation 16.5 (6.2) mm (3.2 mm (1.2%); range 6–
31 mm) and mean COV 1.2 (0.4%) (range 0.4–2.4%). In
relation to the mean CCT at each time point, the difference
between peak CCT (at 4 am) and trough CCT (at 4 pm) was
about 9 mm (p,0.0001). This may reflect the well documen-
ted changes in corneal metabolism occurring during the
night, with increased lactate and corneal swelling.43
The circadian CCT curve in the present study was very
similar to that of Doughty’s meta-analysis of normal, non-
white subjects,34 except for the fact that our fluctuations were
smaller (plus or minus 1% v plus or minus 2%). This may
have been because of the high degree of intraobserver
reproducibility in our study, or to the absence of some
factors that may increase CCT variability, such as preg-
nancy,44 menstruation,45 or oral contraceptive use.46 As shown
in figure 7, both curves intersected the 100% line between
10 am and noon, which is probably the best time to measure
CCT as it is nearest to its mean value.
There was a good correlation between mean supine IOP
and mean CCT (r= 0.53), which confirms that an increase in
CCT is associated with an increase in IOP. The fluctuations in
CCT did not correlate with the other clinical parameters of
mean CCT, mean IOP, IOP fluctuations, or refraction.
Harper36 found that CCT varied by 7.2% over 48 hours
(with an interval of about 6 hours during the night), as
against the 3.2% observed in our study in which the
measurements were continued every 4 hours even during
the night. One possible reason for decreased variability in the
present study is that disturbances in normal sleep-wake
rhythms may change corneal metabolism during the night.
CCT measurements can be theoretically affected when
made by means of an ultrasonic pachymeter after applana-
tion tonometry, but two previous studies21 37 found no
significant influence, and Damji37 strongly recommended
measuring IOP before CCT. Only one study35 has measured
CCT before tonometry.
Although avoided in other studies on the grounds that the
use of a local anaesthetic may disrupt the epithelial barrier,
we followed the usual clinical practice of instilling one drop
of oxybuprocaine before our IOP and CCT measurements in
order to allow more reliable measurements of both; however,
biomicroscopy was regularly used to exclude any changes in
the corneal surface at each time point.
It would have been ideally preferable to obtain data from
untreated patients because CCT and its variability may be
influenced by glaucoma treatment. It has been found that
Table 3 CCT analysis of variance
Source of variation
Degrees of
freedom Sums of squares Mean square F test p Value
Patients 29 267912,561 9238,364 300 ,0.0001
Time points 5 2156,361 431,272 14 ,0.0001
Residual 145 4465,806 30,799
Total 179 274534,728
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Figure 7 Percentage CCT fluctuations over 24 hours in this study (solid
line, plus or minus 1%) and Doughty’s meta-analysis (broken line, plus or
minus 2%). Both curves intersect the 100% line at about 10 am/noon;
this is reasonably the best interval in which to measure CCT as it is
nearest to its mean value.
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timolol may increase CCT47 and latanoprost may decrease it,48
but the differences from baseline were small (within plus or
minus 1%) and can be considered clinically negligible. We
therefore preferred to study a homogeneous sample of POAG
patients identically treated with the unfixed combination of
timolol and latanoprost. No data have been published
concerning the effect of glaucoma treatment on circadian
fluctuations in CCT.
In conclusion, our data relating to glaucomatous patients
suggest that, although statistically significant, circadian CCT
fluctuations do not significantly influence circadian IOP
measurements, which are crucial when considering glaucoma
therapy. With respect to the assumption of Doughty’s meta-
analysis that ‘‘for eyes with chronic disease, […] even modest
changes (that is, 10%) in CCT can be expected to have a
measurable impact on tonometry measures,’’34 we found
fluctuations of only 3%.
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